Showing results (61-70 of 210) with videos related to
Sort By:
Pageof 21
Pharmacology & Therapeutics|December 7, 2016
Current and novel insights into the neurophysiology of migraine and its implications for therapeuticsSimon Akerman, Marcela Romero-Reyes, Philip R HollandBritish Journal of Pharmacology|September 14, 2023
PACAP-38 related modulation of the cranial parasympathetic projection: A novel mechanism and therapeutic target in severe primary headacheSimon Akerman, Peter J Goadsby, Marcela Romero-ReyesBrain Research|November 12, 2002
The role of histamine in dural vessel dilationSimon Akerman, David J Williamson, Holger Kaube, et al.European Journal of Pharmacology|October 2, 2002
The effect of anti-migraine compounds on nitric oxide-induced dilation of dural meningeal vesselsSimon Akerman, David J Williamson, Holger Kaube, et al.Pain|March 30, 2016
Neuropeptide Y inhibits the trigeminovascular pathway through NPY Y1 receptor: implications for migraineMargarida-Martins Oliveira, Simon Akerman, Isaura Tavares, et al.Cephalalgia : an International Journal of Headache|August 25, 2017
Comparative effects of traditional Chinese and Western migraine medicines in an animal model of nociceptive trigeminovascular activationYonglie Zhao, Margarida Martins-Oliveira, Simon Akerman, et al.The Journal of Headache and Pain|October 28, 2010
A potential nitrergic mechanism of action for indomethacin, but not of other COX inhibitors: relevance to indomethacin-sensitive headachesOliver Summ, Anna P Andreou, Simon Akerman, et al.Current Opinion in Neurology|March 4, 2021
Facial pain beyond trigeminal neuralgiaArne May, Jan HoffmannCurrent Pain and Headache Reports|September 3, 2013
Migraine and triggers: post hoc ergo propter hoc?Jan Hoffmann, Ana RecoberExpert Review of Neurotherapeutics|December 21, 2012
Scientific advances in headache research: an update on neurostimulationJan Hoffmann, Delphine MagisPageof 21